Wells Fargo & Company Magenta Therapeutics, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.62 - $0.79 $8 - $10	13 Added 1.7%	779 $0
Q1 2023 May 12, 2023	BUY	$0.41 - $0.86 $2 - $4	5 Added 0.66%	766 $0
Q4 2022 Feb 13, 2023	SELL	$0.36 - $1.59 $534 - $2,359	-1,484 Reduced 66.1%	761 $0
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $4,232 - $7,020	-3,359 Reduced 59.94%	2,245 $3,000
Q2 2022 Aug 12, 2022	BUY	$0.97 - $3.08 $3,790 - $12,036	3,908 Added 230.42%	5,604 $7,000
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $27,055 - $55,490	-10,610 Reduced 86.22%	1,696 $5,000
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $68,877 - $129,514	-15,548 Reduced 55.82%	12,306 $54,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $166,299 - $270,956	27,397 Added 5994.97%	27,854 $203,000
Q2 2021 Aug 16, 2021	SELL	$9.76 - $14.15 $20,886 - $30,281	-2,140 Reduced 82.4%	457 $4,000
Q1 2021 May 13, 2021	SELL	$7.66 - $13.38 $119,473 - $208,687	-15,597 Reduced 85.73%	2,597 $30,000
Q4 2020 Feb 09, 2021	BUY	$6.1 - $7.94 $38,442 - $50,037	6,302 Added 52.99%	18,194 $143,000
Q3 2020 Nov 05, 2020	SELL	$6.52 - $8.94 $52 - $71	-8 Reduced 0.07%	11,892 $81,000
Q2 2020 Aug 13, 2020	SELL	$6.18 - $10.76 $46,374 - $80,743	-7,504 Reduced 38.67%	11,900 $89,000
Q1 2020 May 14, 2020	BUY	$6.03 - $15.24 $117,006 - $295,716	19,404 New	19,404 $122,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.